Amicogen, Inc. (092040.KQ) — Stock Score Summary

Amicogen, Inc. (092040.KQ) has a MoatMap StockRank of 12/100 based on Quality (27/100), Value (51/100), and Momentum (17/100) factor scores. The current signal is STRONG SELL. While Amicogen operates in the industrial enzyme and biopharma materials space, its low quality score (Q: 27) and lack of scale prevent it from capitalizing on the CDMO pricing power cycle.

Amicogen, Inc. develops and manufactures industrial enzymes, biocatalysts, and specialized active pharmaceutical ingredients (APIs). The company's competitive moat is built on its proprietary gene evolution technology, which enables the eco-friendly synthesis of antibiotics and other complex molecules. It operates as a specialized biotechnology leader, driving the transition toward green chemistry in the global pharmaceutical manufacturing sector.

Key Financial Metrics

Price$0.85
Market Cap$58M
Price/Book0.76
Return on Equity-4.0%
Return on Invested Capital-14.6%
Debt/Equity46.70
Gross Margin14.7%
Operating Margin-26.0%
Revenue Growth13.5%
Free Cash Flow$-950.51

Amicogen, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Amicogen, Inc.’s (092040.KQ) StockRank?
MoatMap’s StockRank for Amicogen, Inc. (092040.KQ) is 12/100, with a Strong Sell signal. It is a composite of Quality (27), Value (51), and Momentum (17) factor ranks across MoatMap’s 19,000+ stock universe.
Does Amicogen, Inc. have an economic moat?
Amicogen, Inc. (092040.KQ) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Amicogen, Inc. a buy, hold, or sell?
MoatMap’s current signal for Amicogen, Inc. (092040.KQ) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Amicogen, Inc. in?
Amicogen, Inc. (092040.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks092040.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock